C H Hoke Jr
Overview
Explore the profile of C H Hoke Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
518
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gouvea V, Snellings N, Cohen S, Warren R, Myint K, Shrestha M, et al.
Virus Res
. 1998 Feb;
52(1):87-96.
PMID: 9453147
Hepatitis E has been the predominant type of acute hepatitis in Nepal both in adults and children, in sporadic and epidemic forms. We examined six hepatitis E virus (HEV) isolates...
12.
Drabick J, Gambel J, Gouvea V, Caudill J, Sun W, Hoke Jr C, et al.
Am J Trop Med Hyg
. 1997 Nov;
57(4):449-54.
PMID: 9347962
In the fall of 1995, within a month of deployment to Haiti for peacekeeping duty, four Bangladeshi soldiers developed acute icteric hepatitis in rapid succession. Hepatitis E virus (HEV) was...
13.
Trofa A, DeFraites R, Smoak B, Kanesa-thasan N, King A, Burrous J, et al.
JAMA
. 1997 May;
277(19):1546-8.
PMID: 9153369
Objective: To describe clinical manifestations and public health implications of an outbreak of dengue fever (DF) during Operation Uphold Democracy, Haiti, 1994. Design: Consecutive sample. Setting: Military combat support hospital,...
14.
Vaughn D, Hoke Jr C, Yoksan S, LACHANCE R, Innis B, RICE R, et al.
Vaccine
. 1996 Mar;
14(4):329-36.
PMID: 8744561
A live-attenuated dengue 2 vaccine (strain 16681 PDK 53) developed at Mahidol University, Thailand was evaluated for safety and immunogenicity by administering 10(4) p.f.u. subcutaneously to ten flavivirus non-immune American...
15.
Srivastava A, Putnak J, Warren R, Hoke Jr C
Vaccine
. 1995 Sep;
13(13):1251-8.
PMID: 8578812
A gene fragment encoding the C-terminal 204 amino acids (AA) from the structural envelope glycoprotein (E) and the N-terminal 65 AA from non-structural protein one (NS1) of dengue type 2...
16.
Pang L, Alencar F, Cerutti Jr C, Milhous W, Andrade A, Oliveira R, et al.
Am J Trop Med Hyg
. 1995 Apr;
52(4):347-8.
PMID: 7741175
This is the first report of serologic evidence of hepatitis E infection in Brazil. During a community-based survey of healthy individuals, six of 97 gold miners in the Amazon region...
17.
DeFraites R, Feighner B, Binn L, Kanjarpane D, Delem A, MacArthy P, et al.
J Infect Dis
. 1995 Mar;
171 Suppl 1:S61-9.
PMID: 7876651
To study the feasibility of using inactivated hepatitis A vaccine for rapid immunization of US soldiers, 276 randomized seronegative volunteers received one of four regimens: two injections, on day 0...
18.
Hoke Jr C, Egan J, Sjogren M, Sanchez J, DeFraites R, MacArthy P, et al.
J Infect Dis
. 1995 Mar;
171 Suppl 1:S53-60.
PMID: 7876650
Military personnel are an important target population for hepatitis A immunization. Soldiers are often given vaccines by jet injector and may be required to receive multiple vaccines at one time....
19.
Kurane I, Innis B, Hoke Jr C, Eckels K, Meager A, Janus J, et al.
J Clin Lab Immunol
. 1995 Jan;
46(1):35-40.
PMID: 9363590
It is accepted that T cells play a critical role during virus infections; however, T cell responses in vivo in acute stage of virus infection are not understood. We examined...
20.
Green S, Kurane I, Edelman R, Tacket C, Eckels K, Vaughn D, et al.
J Virol
. 1993 Oct;
67(10):5962-7.
PMID: 8371350
We analyzed the CD4+ T-lymphocyte responses to dengue, West Nile, and yellow fever viruses 4 months after immunization of a volunteer with an experimental live-attenuated dengue virus type 1 vaccine...